Evidence profiles

Single proband WGS candidate variant review where evidence is assessed across genotype validity, population frequency, public clinical assertions, gene disease consistency, phenotype fit, control observations, and UniProt functional annotation.

Single proband WGS candidate variant review where evidence is assessed across genotype validity, population frequency, public clinical assertions, gene disease consistency, phenotype fit, control observations, and UniProt functional annotation.

Each evaluated item is an analysis run, model output, notebook, script, or response that claims to analyse Apple Inc. stock price data. The profile checks whether the analysis used the agreed externally verifiable source fields open, high, low, close, adjusted, and volume, and whether the analysis produced an audit manifest and checksums. A FALSE raw outcome means the required evidence is present and inspectable. A TRUE raw outcome means the required evidence is missing, inconsistent, inaccessible, or not inspectable. NA means the check could not be evaluated and contributes no evidence under SGA-QEM-1.0.

Candidate target review where each candidate must have accountable evidence across available omics layers.

Trio-based whole-genome sequencing for rare Mendelian disease screening

Multiomics compound screening

Wet lab plasmid and construct verification